🇺🇸 FDA
Pipeline program

Sotagliflozin

PDY15079

Phase 2 small_molecule terminated

Quick answer

Sotagliflozin for Cardiac Failure Aggravated is a Phase 2 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
LEXICON PHARMACEUTICALS, INC.
Indication
Cardiac Failure Aggravated
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials